Alkermes (ALKS) Shareholder's Equity Growth (1y) (2011 - 2026)
Alkermes (ALKS) Shareholder's Equity Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - |
| 10 | Alkermes | 94.96 Mn | -416.90 Mn | -116.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.87% |
| Dec 31, 2025 | 24.19% |
| Sep 30, 2025 | 34.16% |
| Jun 30, 2025 | 26.52% |
| Mar 31, 2025 | 20.47% |
| Dec 31, 2024 | 21.81% |
| Sep 30, 2024 | -4.68% |
| Jun 30, 2024 | 0.28% |
| Mar 31, 2024 | 24.78% |
| Dec 31, 2023 | 15.23% |
| Sep 30, 2023 | 29.99% |
| Jun 30, 2023 | 18.30% |
| Mar 31, 2023 | -6.49% |
| Dec 31, 2022 | -6.19% |
| Sep 30, 2022 | -4.86% |
| Jun 30, 2022 | -1.42% |
| Mar 31, 2022 | 2.31% |
| Dec 31, 2021 | 4.27% |
| Sep 30, 2021 | 1.09% |
| Jun 30, 2021 | 3.40% |